title: Severe creatine kinase increase during quetiapine and mirtazapine treatment.
authors.forename: Sule
authors.initials: S
authors.lastname: Apikoglu Rabus
authors.forename: Fikret
authors.initials: F
authors.lastname: Izzettin
authors.forename: Murat
authors.initials: M
authors.lastname: Rabus
authors.forename: Mustafa
authors.initials: M
authors.lastname: Bilici
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy; D003402:Creatine Kinase / Q000097:blood*; D003987:Dibenzothiazepines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008803:Mianserin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D000069348:Quetiapine Fumarate
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D008803:Mianserin; D000069348:Quetiapine Fumarate; D000078785:Mirtazapine; D003402:Creatine Kinase